Evidence map›Paper›PMID 24788074›Full record

ArticleMicrovascular research2014

Characterization of nanoparticle delivery in microcirculation using a microfluidic device.

Antony Thomas, Jifu Tan, Yaling Liu

Abstract read
In one paragraph

Article in Microvascular research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Antony ThomasBioengineering program, Lehigh University, Bethlehem, PA 18015, USA. Electronic address: ant210@lehigh.edu.
Jifu TanDepartment of Mechanical Engineering and Mechanics, Lehigh University, Bethlehem, PA 18015, USA. Electronic address: jit310@lehigh.edu.
Yaling LiuBioengineering program, Lehigh University, Bethlehem, PA 18015, USA; Department of Mechanical Engineering and Mechanics, Lehigh University, Bethlehem, PA 18015, USA. Electronic address: yal310@lehigh.edu.

Funding

An Integrated Biometric Platform for Evaluation of Nanomedicine DeliveryR15EB015105 · NIBIB · LEHIGH UNIVERSITY · PI LIU, YALING · 2013 to 2013
$443k
NIBIB NIH HHS EB015105NIBIB NIH HHS R15 EB015105
6 · The paper itself

Abstract

This work focuses on the characterization of particle delivery in microcirculation through a microfluidic device. In microvasculature the vessel size is comparable to that of red blood cells (RBCs) and the existence of blood cells largely influences the dispersion and binding distribution of drug loaded particles. The geometry of the microvasculature leads to non-uniform particle distribution and affects the particle binding characteristics. We perform an in vitro study in a microfluidic chip with micro vessel mimicking channels having a rectangular cross section. Various factors that influence particle distribution and delivery such as the vessel geometry, shear rate, blood cells, particle size, particle antibody density are considered in this study. Around 10% higher particle binding density is observed at bifurcation regions of the mimetic microvasculature geometry compared to straight regions. Particle binding density is found to decrease with increased shear rates. RBCs enhance particle binding for both 210 nm and 2 μm particles for shear rates between 200-1600 s(-1) studied. The particle binding density increases about 2-3 times and 6-10 times when flowing in whole blood at 25% RBC concentration compared to the pure particle case, for 210 nm and 2 μm particles respectively. With RBCs, the binding enhancement is more significant for 2 μm particles than that for 210 nm particles, which indicates an enhanced size dependent exclusion of 2 μm particles from the channel centre to the cell free layer (CFL). Increased particle antibody coating density leads to higher particle binding density for both 210 nm and 2 μm particles.

Indexed as

Drug CarriersMicrocirculationAnimalsAntibodiesDimethylpolysiloxanesErythrocytesGoatsHumansIntercellular Adhesion Molecule-1MiceMicrofluidic Analytical TechniquesMicrofluidicsMicroscopy, ConfocalMicrovesselsNanoparticlesParticle SizeAntibodiesDimethylpolysiloxanesDrug CarriersIntercellular Adhesion Molecule-1PolystyrenesBifurcation regionMicrocirculationMicrofluidic chipMicrovasculatureNanoparticleParticle distributionRed blood cellsShear rate

Identifiers

PMID24788074
PMCPMC4111996

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.